Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
719.60
+16.25 (2.31%)
At close: Sep 5, 2025

Senores Pharmaceuticals Company Description

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics; and management and consultancy services.

Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.

Senores Pharmaceuticals Limited
CountryIndia
Founded2017
IndustryDrug Manufacturers - General
SectorHealthcare
Employees194
CEOSwapnil Shah

Contact Details

Address:
South Tower
Ahmedabad, Gujarat 380054
India
Phone91 79 2999 9857
Websitesenorespharma.com

Stock Details

Ticker SymbolSENORES
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE0RB801010
SIC Code2834

Key Executives

NamePosition
Swapnil Jatinbhai ShahMD and Director
Deval Rajnikant ShahWhole-Time Director and Chief Financial Officer
Chetan Bipinchandra ShahWhole-Time Director and Chief Operating Officer
Hanuwant Singh ShaktawatAssistant Vice President of Human Resources and Admin
Vinay Kumar MishraCompany Secretary and Compliance Officer
Deepak JainVice President of Regulatory Affairs
Jignesh Shashikant DesaiPresident of Finance